Rabies Risk Reduction Program

The program aims to reduce the risks of rabies virus extension by introducing monitoring of vaccination measures effectiveness by serodiagno

Photo of Nadezhda Iskenderova
0 5

Written by

I confirm that I am fully aware of the eligibility criteria and terms of the Purina BetterwithPets Prize and, based on its description, I am eligible to apply:

  • Yes, I’m eligible
  • Yes, I’m 18 years old or older

Should you be successful, please confirm your availability to attend:

  • Additional Skype interview(s) during the week of March 16-20th 2020
  • The Purina BetterwithPets Forum in Paris, on 3-4th of June 2020

Initiative's representative name

Nadija Iskenderova

Initiative's representative date of birth

9081993

Initiative's representative gender

  • Woman

Headquarters location: country

  • Russia

Headquarters location: city

Belgorod

Where are you making a difference?

Central Federal District of Russia

Website or social media url(s)

http://ns-rabies.ru/

Date Started

07/2020

Focus Areas

  • Elimination of common diseases for humans and animals

What is your current yearly budget for the initiative? If you are an idea stage, what early budget you would need to kick-off and run operations in your first year?

  • €100k - €250k

Organisation Type

  • for profit: an organisations whose main goal is to make income through business gains

1. Founding story: Share a story about the "Aha!" moment that led the founder(s) to get started or the story of how you saw the potential for this project to succeed.

Rabies is a dangerous disease that is fatal in almost 100% of cases after a visible manifestation of symptoms. This disease is common to many animals and humans. Rabies is effectively prevented by vaccine preventive measures, so in many countries it has not been detected in the last few decades. According to media reports, only in one month (August 2019), 73 cases of rabies were recorded in Russia. The leaders in detecting cases of rabies are Belgorod, Moscow, Kaluga and Tambov regions. The measures taken by the state are necessary, but not sufficient. In view of the foregoing, the idea of the need for our contribution to the fight against this disease arose.

2. The problem: What problem are you helping to solve?

The extension of infectious diseases common to humans and animals is an important issue. Thus, rabies poses a significant threat not only to domestic animals, but also to humans. The elimination of such dangerous diseases is one of the key challenges of the 21st century.

3. Your solution: How are you planning to solve this problem? Share your specific approach.

We plan the following measures: Improvement of rabies vaccine prevention program. Creation of a system for monitoring the effectiveness of vaccination. Rabies is one of the most dangerous disease common to humans and animals that is fatal in almost 100% of cases after a visible manifestation of symptoms Interaction with government agencies on the implementation of a system for monitoring the effectiveness of anti-rabies measures

4. Innovation: How are you innovating or using unique approaches to solve the problem?

Organizational measures under development to improve the anti-rabies vaccine prevention program and monitor its effectiveness are innovative. The development of educational programs and the provision of wide coverage of territories of rabies-disadvantaged territories is also innovative. Work is planned to improve tests to determine the titer of rabies virus antibodies in the blood of animals

5. How does your project harness the pet-human bond to help people develop important social competencies (For example: emotional intelligence, collaboration, empathy, resilience, inclusivity) and overcome serious societal issues (for example: violence, abuse, trauma, isolation, abandonment)?

The pet-human bond can carry not only beneficial effects, but also some risks. One of these risks is the risk of contracting dangerous diseases common to humans and animals. The risk of spreading rabies by a pet poses a threat to a person, inculcates fear. Overcoming this problem will increase the stability of the interaction between humans and animals.

6. Impact: how has your project made a difference so far in terms of both business outputs and social impact? How do you plan on measuring progress?

The development of serodiagnostic assay services (determining the titer of antibodies to rabies virus in blood of animals) will allow for widespread improvement and social quality control of vaccines (production and distribution), as well as social quality control of veterinary services (vaccination). Also, this will lead to a reduction in the risk of a disease dangerous to humans. Measuring progress in this area will be determined by increasing the detection rate of substandard vaccines or vaccination services, as well as by reducing the incidence of rabies.

7. Growth strategies: what are your main strategies for scaling your impact?

Conducting seminars and lectures in veterinary clinics, universities, among associations of animal owners on the issue of monitoring the effectiveness of vaccination of animals against rabies in large cities of Russia, Belarus, Kazakhstan and other EurAsEC countries. Branches will be opened in large cities and a logistics system will be established. Implementation of a system for monitoring vaccination efficacy at the regional and federal levels.

8. Creating shared value: How does your initiative create value for different stakeholders?

The program implementation initiative creates the following value: - carrying out serodiagnostic assay services for the titer of antibodies to rabies virus; - reducing the risk of spreading a dangerous disease; - development of biotechnology and virology; - increasing human confidence in the pet.

9. Financial sustainability plan: can you tell us about your plan to fund your project and how that plan will be sustainable in the short, medium, and long term?

Novosystem has the only anti-rabies laboratory in Russia independent of the state, accredited by ANSES for determining the titer of antibodies to rabies virus in the blood of animals. It has more than 100 partner clinics in 7 countries. Logistics established. Short term: the creation of up to 20 branches of the company in major cities of Russia and neighboring countries. Medium term: implementation of WHO and OIE resolutions on rabies prevention through these branches. The expansion of the customer base. Long term: the creation through these branches of educational programs and system of international monitoring the effectiveness of rabies vaccination.

10. Team: what is the current composition of your team (types of roles, qualifications, full-time vs. part-time, board members, etc.), and how do you plan to evolve the team’s composition as the project grows?

The team that ready to begin the project has 13 people. It includes 3 candidates of sciences (PhD); 3 graduate students; 7 qualified specialists. The team has experienced economists and marketers. Dream Team: Opening 20-30 branches in over the world, expanding the central office to improve the quality and effectiveness of analytical work, conducting educational work.

11. How do you plan to influence your field of work if you are a winner of this edition of the Purina BetterwithPets Prize?

We will start to complete the development and run Rabies Risk Reduction Program

12. How did you hear about this challenge?

  • Recommended by others

0 comments

Join the conversation:

Comment